Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens.

Area of Science:

• Infectious Diseases
• Microbiology
• Pharmacology

Background:

• Antimicrobial resistance (AMR) poses a significant global health challenge, leading to increased mortality and therapeutic failures.
• Vulnerable populations, including the elderly and immunocompromised, are at higher risk of severe illness due to AMR.
• Projected to cause 10 million deaths annually by 2050, AMR necessitates urgent global action.

Purpose of the Study:

• To review and analyze novel therapeutic strategies beyond traditional antibiotics for combating multidrug-resistant bacterial infections.
• To evaluate the benefits and limitations of emerging alternative treatments for AMR.

Main Methods:

• This narrative review synthesizes current research on alternative antimicrobial strategies.
• Key alternative approaches examined include monoclonal antibodies, microbiome modulators, nanomaterial-based therapeutics, vaccines, and bacteriophages.

Main Results:

• New therapeutic avenues show promise in addressing multidrug-resistant bacterial infections.
• Each alternative strategy presents unique advantages and challenges that require further investigation.
• The decline in novel antibiotic development underscores the importance of exploring these alternative options.

Conclusions:

• Alternative therapeutic strategies offer potential solutions to the AMR crisis.
• Further research and development are crucial to realize the full potential of these novel treatments.
• A multi-faceted approach is needed to combat the growing threat of antimicrobial resistance.